NRXP NRx Pharmaceuticals, Inc.

bearish REVERSAL track record → $2.94 +0.10 (+3.5%)
Get emailed when NRXP changes direction
Mkt Cap $99M 52wk $1.62 - $3.84 Earnings 2026-05-15 1h ago
Insider buying: $65,600 bought by 1 insider (30d)
Factor divergence: DIVERGENCE: options_sentiment bullish vs estimate_revisions, analyst_revisions, narrative_gap bearis
Est. revisions: -450.0%
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -3.1)

Factor Model

net -3.1 5.8 / 10
Est. Revisions
-1.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
-0.5

NRXP short interest surges 29% to 3.25M

Watch: Monitor FDA approval news and commercial traction in HOPE Therapeutics clinics for signs of shift in sentiment or short squeeze potential.

Short interest in NRx Pharmaceuticals jumped 29.4% to 3,248,961 shares, or 10.4% of the float. Days to cover rose to 3.6, signaling increased bearish pressure despite recent buy ratings from three firms. The stock trades near its 52-week low with a 15% weekly bounce amid heavy short activity and high put/call ratio of 15.2.

The surge in short interest indicates growing skepticism on the near-term path, potentially clashing with bullish analyst buy ratings and upcoming FDA decision in summer 2026.

Evidence

3h ago Short interest surged 29% to 3,248,961 shares
20h ago HC Wainwright & Co. reit NRXP: Buy → Buy
1d ago Ascendiant Capital main NRXP: Buy → Buy
5d ago D. Boral Capital main NRXP: Buy → Buy
8d ago D. Boral Capital main NRXP: Buy → Buy
14d ago Insider buy by JAVITT JONATHAN C (NRXP): $65,600
32d ago NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101 yahoo-finance
54d ago NRx Builds Momentum From FDA Progress To Strategic Expansion benzinga
1 older signals
61d ago NRx Builds Momentum From FDA Progress To Strategic Expansion
Fundamentals & Data ▾
NRx Pharmaceuticals, Inc. Healthcare · Biotechnology
Mkt Cap
$99M
Beta
1.83
52w Range
$1.62 - $3.84
Short Interest
3.2M 10.38%
Days to Cover
3.6 +18%
Technicals downtrend
from 52w Hi
-8.1%
1w return
+15.3%
Insiders
buying 1B / 0S
Analysts
mixed
EPS Estimate
$-0.11 -450.0% 30d 0up / 1dn
Est. Dispersion
0% 1 analysts
Analyst Target
$38 $25 - $49
Options P/C
15.22
Top Holders
Citadel
Recent Filings & Data
insider trade 1
net buying · $65,600 bought
1 insider · 1 transactions (30d)
Recent transactions
JAVITT JONATHAN C · buy · $65,600
9 signals · latest 3h ago

Get alerted when NRXP changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →